The Broad Array of Vaccine Options for COVID-19
As we pass the two-year anniversary of the start of the coronavirus pandemic, we are reminded of where we started and how far we have…
Answering Your Questions on Developing a Relative Potency Assay for an Anti-Influenza mAb
Dr. Jeff Patrick answers questions on how BioAgilytix translated a diagnostic virus neutralization method to a quantitative relative potency assay for an anti-viral antibody.